Therapy Areas: Respiratory
20 November 2018 - Anglo–Swedish multinational pharmaceutical and biopharmaceutical company AstraZeneca's Imfinzi (durvalumab) monotherapy and the combination of Imfinzi with remelimumab ha...
20 November 2018 - The US Food and Drug Administration (FDA) has approved the expansion of the label for Switzerland-based Novartis' Promacta (eltrombopag) to include first-line treatment for adu...
19 November 2018 - - German drugmaker Boehringer Ingelheim and US-based Epizyme, Inc. (NASDAQ: EPZM) have forged a new global collaboration focused on the research, development and commercialization o...
19 November 2018 - South Korean biotech company Bridge Biotherapeutics Inc disclosed on Monday that it has submitted its Investigational New Drug (IND) application with the US Food and Drug Administra...
19 November 2018 - Medicines company Novartis reported on Friday the receipt of approval from the US Food and Drug Administration (FDA) to expand the label for Promacta to include first-line treatment...
19 November 2018 - Germany-based Boehringer Ingelheim has signed a new global collaboration with United States-based Epizyme to develop novel epigenetic oncology therapies, it was reported on Friday.T...